1-4 of 4
Finn Skou Pedersen
Close
Sort by
Journal Articles

Gene Expression Profiling of Murine T-Cell Lymphoblastic Lymphoma Identifies Deregulation of S-Phase Initiating Genes.

Karen Dybkaer, Magdalena Julia Dabrowska, PhD, Ditte Ejegod, PhD, Louise Berkhoudt Lassen, PhD, Hans Erik Johnsen, Matthias Wabl, Finn Skou Pedersen
Journal: Blood
Blood (2012) 120 (21): 2395.
https://doi.org/10.1182/blood.V120.21.2395.2395
Published: 2012
Journal Articles

Infliximab Drives Gamma-Delta T Cell Expansion In Crohn's Disease – a Predictor of Lymphoma Risk?

Jens Kelsen, Heinrich Schwindt, Anders Dige, Francesco d'Amore, Finn Skou Pedersen, J∅rgen Agnholt, Lisbet Ambrosius Christensen, Jens Frederik Dahlerup, Christian Lodberg Hvas
Journal: Blood
Blood (2010) 116 (21): 4131.
https://doi.org/10.1182/blood.V116.21.4131.4131
Published: 2010
Journal Articles

Impact of Growth Factor Independence 1 in Human T-Cell Lymphomas; Pathogenic Potential Identified by Insertional Mutagenesis in a Murine T-Cell Lymphoma Model.

Magdalena Julia Dabrowska, Karen Dybkaer, Preben Johansen, Hans Erik Johnsen, Finn Skou Pedersen
Journal: Blood
Blood (2009) 114 (22): 5047.
https://doi.org/10.1182/blood.V114.22.5047.5047
Published: 2009
Journal Articles

A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus

Sys Zoffmann Glud, Annette Balle Sørensen, Mindaugas Andrulis, Bruce Wang, Eisaku Kondo, Randi Jessen, Laszlo Krenacs, Eva Stelkovics, Matthias Wabl, Edgar Serfling, Alois Palmetshofer, Finn Skou Pedersen
Journal: Blood
Blood (2005) 106 (10): 3546–3552.
https://doi.org/10.1182/blood-2005-02-0493
Published: 2005